Muna Therapeutics:
Muna Therapeutics, a Copenhagen, Denmark based biopharmaceutical company founded in 2020, is dedicated to discovering and developing transformative therapeutics for neurodegenerative diseases. With a focus on Alzheimer’s, Frontotemporal Dementia, and Parkinson’s, the company aims to combat the devastating impact of these disorders on millions of patients globally. Their pioneering efforts in identifying new medicines to preserve cognition and other brain functions while enhancing resilience to neurodegenerative diseases are captured by their name, Muna, which means 'to remember' in Old Norse. The recent $4.90M grant investment in October 11, 2022 from the Michael J. Fox Foundation underscores the promising potential and innovative approach of Muna Therapeutics in addressing critical unmet medical needs in the field of neurodegenerative diseases. Muna Therapeutics operates within the Biopharma, Biotechnology, and Pharmaceutical industries, positioning itself as a promising player in the quest to develop life-changing therapies for patients suffering from neurodegenerative conditions.
Muna Therapeutics
Discovering and developing transformative therapeutics for neurodegenerative diseases
Founded 2020
Denmark
54 employees
Grant
Total: $77.90M
Biopharma, Biotechnology +1
Denmark
54 employees
Grant
Total: $77.90M
Biopharma, Biotechnology +1
General Information
Company Name
Muna Therapeutics
Founded Year
2020
Location
Denmark
Denmark
Founders / Decision Makers
Employees
54
Industries
Biopharma, Biotechnology, Pharmaceutical
Funding Stage
Grant
BounceWatch is an independent company data service, not affiliated with Muna Therapeutics. To contact Muna Therapeutics, visit munatherapeutics.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Muna Therapeutics compare?
A PDF of Muna Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Muna Therapeutics soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
Denmark Market
Biopharma
About Muna Therapeutics
Business keywords: Biopharmaceutical, Neurodegenerative diseases, Therapeutics, Alzheimer’s, Frontotemporal Dementia, Parkinson’s, Cognitive preservation, Brain function enhancement, Drug discovery, Research and development, Memory, Movement, Behavioral disorders, Copenhagen
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | $4.90M | 1 |
|
11 Oct 2022 |
| Series A | $73.00M | 8 |
|
09 Jul 2021 |
Muna Therapeutics Alternatives & Competitors
View All Alternatives
Muna Therapeutics vs
Sharp Therapeutics
United States
Developing small molecule drugs for genetic diseases..
10 employees
Biopharma, Biotechnology
Muna Therapeutics vs
Cognition Therapeutics, Inc.
United States
Advancing Accessible Solutions for Complex Neurodegenerative Diseases
IPO
29 employees
Biotechnology, Health Care
Muna Therapeutics vs
Cantabio Pharmaceuticals, Inc.
United States
Cantabio aim to slow, stop and even prevent the onset & progression of neurodegenerative diseases.
Grant
13 employees
Biotechnology, Pharmaceutical
FAQ About Muna Therapeutics
Discovering and developing transformative therapeutics for neurodegenerative diseases
Muna Therapeutics was founded in 2020.
Muna Therapeutics is headquartered in Denmark.
Muna Therapeutics operates in Biopharma, Biotechnology and Pharmaceutical. Its work centres on Biopharmaceutical, Neurodegenerative diseases, Therapeutics and Alzheimer’s.
Muna Therapeutics has approximately 54 employees.
Muna Therapeutics has completed 2 funding rounds, raising a total of $77.90M. The latest funding stage is Grant.
Top alternatives and competitors to Muna Therapeutics include Sharp Therapeutics, Cognition Therapeutics, Inc., Cantabio Pharmaceuticals, Inc., Cerevance, Alchemab Therapeutics Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Muna Therapeutics and Sharp Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for Muna Therapeutics, https://bouncewatch.com/company/muna-therapeutics, updated 30 December 2024. When citing, please name BounceWatch and link this page.
